comparemela.com
Home
Live Updates
Imforte Study - Breaking News
Pages:
Latest Breaking News On - Imforte study - Page 1 : comparemela.com
Overview of Second-Line Treatment Options in SCLC
Expert oncologists Laurent Greiller, MD, and Christian Grohé, MD, reflect on the current state of second-line treatment options for patients with small cell lung cancer.
Laurent greiller
Christian groh
Evolving paradigms
Second line treatment options
Small cell lung cancer
Relapsed refractory sclc
Relapsed refractory small cell lung cancer
Second line therapy
Second line treatment
Sequencing therapy
Time to progression
Maintenance therapy
Trio therapy
Treatment response
Platinum sensitive
Platinum resistant
Clinical Data With Lurbinectedin in Small Cell Lung Cancer
Key opinion leaders share a focused discussion on lurbinectedin and its evolving role in small cell lung cancer following frontline therapy.
Evolving paradigms
Data with lurbinectedin
Small cell lung
Small cell lung cancer
Limited stage sclc
Extensive stage sclc
Ls sclc
Es sclc
Second line therapy
Second line treatment
Imforte trial
Imforte study
Platinum resistant
Platinum sensitive
Maintenance therapy
Adverse events
vimarsana © 2020. All Rights Reserved.